Psychedelic Medicine Company Approved To Study Sublingual Psilocybin For Major Depressive Disorder

Toronto-based Cybin will launch a phase two clinical trial at the University of Jamaica to test its under-the-tongue tab of psilocybin.
Source: Reuters: Health - Category: Consumer Health News Source Type: news